ClinicalTrials.Veeva

Find clinical trials for Lung Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near San Antonio, TX, USA:

Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)

with pemetrexed and platinum chemotherapy in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung ...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Cisplatin
Drug: Datopotamab Deruxtecan

Phase 3

Daiichi Sankyo

San Antonio, Texas, United States and 139 other locations

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

San Antonio, Texas, United States and 30 other locations

and pemetrexed, with or without an anti-PD-1 antibody (pembrolizumab or zimberelimab), in participants with non-squamous Non-Small Cell Lung ...

Active, not recruiting
Non Small Cell Lung Cancer Metastatic
Nonsquamous Nonsmall Cell Neoplasm of Lung
Drug: Zimberelimab
Drug: Etrumadenant

Phase 1

Arcus Biosciences
Arcus Biosciences

San Antonio, Texas, United States and 22 other locations

for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung cancers are due to muta...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 152 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

San Antonio, Texas, United States and 22 other locations

This is an open-label, non-controlled study conducted in two parts - Part A (dose escalation) followed by Part B (dose expansion).

Active, not recruiting
Colorectal Cancer
Pancreatic Cancer
Drug: NBF-006

Phase 1

Nitto BioPharma

San Antonio, Texas, United States and 8 other locations

The main purpose of the study is to evaluate the safety of GDC-1971 in combination with either osimertinib or cetuximab. The study consists of a dose...

Enrolling
Non-Small Cell Lung Cancer
Colorectal Cancer
Drug: GDC-1971
Drug: Cetuximab

Phase 1

Genentech
Genentech

San Antonio, Texas, United States and 7 other locations

deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic non-small cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Datopotamab Deruxtecan
Drug: Pembrolizumab

Phase 3

Daiichi Sankyo

San Antonio, Texas, United States and 229 other locations

maintenance therapy in participants with extensive-stage small-cell lung cancer (ES-SCLC) after first-line induction therapy with c...

Active, not recruiting
Small-Cell Lung Cancer
Drug: Etoposide
Drug: Atezolizumab

Phase 3

Roche
Roche

San Antonio, Texas, United States and 111 other locations

(Dato-DXd) in combination with pembrolizumab with or without platinum chemotherapy in participants with advanced or metastatic non-small cell lung...

Active, not recruiting
Advanced or Metastatic NSCLC
Drug: Cisplatin
Drug: KEYTRUDA®

Phase 1

Daiichi Sankyo

San Antonio, Texas, United States and 23 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems